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EXPERIMENTAL DETERMINATION IN HUMAN SUBJECTS OF THE
DURATION OF "ANTIHISTAMINIC" ACTIVITY OF ORALLY
ADMINISTERED COMPOUNDS
DANIEL J. PERRY, M.D.* AND DAVID L. HEARIN, M.D.t
Numerous so-called antihistaminic drugs have been reported to be beneficial
in the treatment of allergic diseases. Many of the basic laboratory studies of
these compounds have been performed on animals; however, conclusions as to
their anti-allergic effect based on animal experiments do not necessarily apply to
human subjects. Consequently, a controlled method of evaluating the anti-
histamine activity of such drugs in human subjects is of value. Probably the
first study of this kind is that of Baer and Sulzberger (1) who measured the
effectiveness of orally administered Pyribenzamine' in reducing dermographism
in man. Histamine iontophoresis (2) has been used to appraise the anti-
histaminic activity of diphenhydramine hydrochloride,' tripelennamine hydro-
chloride,' Hydryllin,' ephedrine sulfate, aminophyllin and placeboes. Fifty
milligram doses of each of the first three compounds, administered orally, have
shown approximately equal histamine-blocking capacities,4 and were superior
to the other compounds tested in this regard.
Heretofore, the recommended dosage of antihistaminic compounds have been
based primarily on clinical experience and with the exception of reference 1, not
on laboratory studies in human subjects. This paper deals with the application
of histamine iontophoresis to the study of the duration of antihistaminic activity
of single, equal, oral doses of diphenhydramine hydrochloride, tripelennamine
hydrochloride and Hydryllin, thereby more accurately indicating the desirable
frequency of their administration.
METHOD
A complete description of the method of histamine iontophoresis has been
reported (2, 3). Briefly, the electrophoretic apparatus consists of a 45-volt B
battery connected in series to a rheostat and milliammeter. Squares of ifiter
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paper (2 sq. cm.) saturated in each of a series of dilutions of histamine acid
phosphate were separately applied to the flexor surface of either forearm. The
positive electrode (copper) of the same size covered the filter paper, a constant
weight was applied and 2 milliamperes of direct current was induced for 2 minutes
(2). The highest histamine dilution which produced a local diffuse whealing
response was recorded as the initial threshold reaction. Next an antihistaminic
compound was administered orally. Subsequently, the subject was retested to
the same series of histamine base dilutions in 30, 60 and 120 minute intervals.
If no local whealing response resulted from the dilution producing the initial
threshold reaction, more concentrated histamine base solutions were serially
iontophoresed into the flexor surface of the subject's forearm until diffuse local
whealing was obtained. The latter dilution constituted the new threshold level.
For example, one male subject had an initial whealing reaction to a 1/4,000,000
histamine base solution. Fifty milligrams of diphenhydramine hydrochloride
was then administered orally. Thirty minutes later 1/4,000,000 still produced a
local whealing reaction. One hour later no whealing response was obtained to
1/4,000,000, 1/3,000,000 and 1/2,000,000 dilutions. However, iontophoresis of
1/1,000,000 histamine solution produced a local diffuse whealing reaction and
constituted the new threshold level. The 120 minute test showed no change
in threshold. Thus, the oral administration of fifty milligrams of diphenhy-
dramine hydrochloride changed the reactivity of the skin of the flexor surface of
the forearm of this subject so that he was able to tolerate more concentrated
histamine base dilutions before obtaining a whealing response. The exact
mechanism of this alteration is unknown. Recently, the theory that anti-
histaminic substances compete with histamine for the normal histamine-recep-
tive sites has been proposed to explain the mode of action of histamine-antag-
onistic compounds (4).
In the present experiments the same technic of iontophoresis of histamine base
was again utilized. The initial threshold was determined in 45 different normal
subjects who were then divided into three equal groups. One group was given
50 mgm. of diphenhydramine hydrochloride, the second group received 50 mgm.
of tripelennamine hydrochloride; and the last one, 2 tablets of Hydryllin.5 All
three compounds were administered orally. Subsequently, at 1, 2, 3, 4 and 5
hour intervals, threshold whealing reactions to histamine were again determined
in all subjects. The 45 subjects tested varied in age from 19 to 43 and included
19 males and 26 females.
RESULTS
The first step in tabulating the results of our present experiments was to
convert all inital and hourly threshold levels obtained in each of the 45 experi-
ments into their corresponding quantitative histamine values. As shown in
Table 1 each histamine base dilution contained a definite amount of histamine
base per cc. of solution. Thus, a threshold level of 1/2,000,000 contained 0.50
A single tablet of Hydryllin combines 25 mgm. of diphenhydramine and 100 mgm. of
aminophyllin.
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micrograms of histamine base per cc. of solution. This means that a local diffuse
whealing reaction was obtained to the iontophoresis of a solution containing 0.50
micrograms of histamine base per cc. However, in the same individual, at the
same interval of testing, no whealing resulted from electrophoresis of 1/3,000,000
histamine base (0.333 micrograms of histamine base per cc. of solution). In a
TABLE 1
Tabulation of serial histamine dilutions and their corresponding content of histamine base
HISTAMINN DILUTION
1/500,000
1/600,000
1/700,000
1/800,000
1/000,000
1/1,000,000
1/2,000,000
1/3,000,000
1/4, 000, 000
1/5,000,000
1/6,000,000
1/7,000, 000
1/8,000,000
1/9,000,000
1/10,000,000
MICROGRAMS OP HISTAMUIE SALT PER CC. OP SOLUTION
2.000
1.666
1.428
1.250
1.111
1.000
0.500
0.333
0.250
0.200
0.166
0.143
0.125
0.111
0.100
TABLE 2
and hourly histamine values computed in three groups of fifteen subjects tested
with three different antihistaminic compounds
____________________
similar manner, by referring to Table 1, all initial and hourly threshold levels
were converted to their corresponding histamine base content.
The next step was the calculation of the average histamine base concentrations
of the initial, 1, 2, 3, 4 and 5-hour threshold levels in all 45 experiments. This
computation is illustrated by the following example. The initial threshold re-
action of each of the 15 subjects who subsequently received Hydryllin was con-
verted to its corresponding content of histamine base (Table 1). This was
totalled and the summation divided by 15. The result obtained represented the
Average initial
TINE
DIPRRNHYDRAMINE HCI
(AVERAGE MICROGRAMS
RISTAMINE SALT/CC. OP
SOLUTION)
TRIPELENNAMINE HCI
(AVERAGE MICROGRAMS
RISTAISINE SALT/CC. OP
SOLUTION)
HTDRYLLIN (AVERAGE
MICROGRAMS RISTAMINE
SALT/CC. OF SOLUTION)
Initial
1 hour
2 hours
3 hours
4 hours
5 hours
.271
.463
.913
.906
.472
.271
.354
.685
.984
.939
.750
.364
.329
.594
.941
.879
.708
.341
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average initial threshold value in the Hydryllin group. Similarly, averages were
calculated for the 1, 2, 3, 4 and 5-hour thresholds of this same group of 15 sub-
jects. In the same fashion average initial, 1, 2, 3, 4 and 5-hour values were
computed for the diphenhydramine hydrochloride and tripelennamine hydro-
chloride groups. The results are presented in Table 2.
The final step in evaluating our results was the plotting of the average initial
and hourly histamine concentration for each of the three drugs tested (Table 2)
in graphic form (Fig. 1). The abscissa depicts the time in one hour intervals
following the oral administration of an antihistaminic compound. The ordinate
DURATION OF ANTIHSTAMINIC ACTIVITY—3 COMPOUNDS
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shows the average quantity of histamine acid phosphate (micrograms of hista-
mine salt per cc. of solution). (Table 2).
DISCUSSION
"Histamine-blocking" curves of diphenhydramine hydrochloride, tripelen-
namine hydrochloride and Hydryllin have been determined by the application
of the histamine iontophoresis method (2, 3). Following single equal oral doses
of these 3 compounds, the increase, apex and disappearance of antihistaminic
activity has been graphically demonstrated in 45 subjects (Fig. 1).
One hour after the ingestion of each of these three drugs there was some "anti-
histaminie" activity in 31 subjects. In 14 subjects there was no change in the
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threshold level in one hour, however, all showed an increase in threshold in their
two hour test. These 14 subjects were equally divided, 4 being in the diphen-
hydramine hydrochloride, 5 in the tripelennamine hydrochloride and 5 in the
Hydryllin group. Slower absorption from the gastrointestinal tract might
explain the absence of change in the 1 hour threshold determination.
In 37 subjects the average maximum "antihistaminic" activity of all 3 drugs
was obtained 2 hours after their administration. The remaining 8 subjects
attained this peak at their 3 hour threshold determination, possibly also due to
slower absorption from the gastrointestinal tract since their 3 hour peak was as
high as that of the 37 subjects who demonstrated their apex of activity in 2 hours.
In all 45 subjects the average "histamine-blocking" activity for all 3 com-
pounds was sustained in the third hour threshold determination but at an average
level slightly lower than the 2 hour ceiling (except the 8 subjects who reached
their apex of activity in the 3 hour threshold determination).
All subjects showed a definite decline in antihistaminic activity in 4 hours.
In the fifth hour determination, 43 subjects rqturned to their original threshold
levels, indicating that the "histamine-blocking" effect of the 3 compounds
administered disappeared in 5 hours. The remaining 2 subjects had a 5 hour
threshold level only slightly higher than their initial one so for practical purposes
also lost their antihistaminic effect in 5 hours.
The present experiments indicate that the 3 compounds tested apparently
have similar curves of histamine-antagonistic activity from which certain clinical
applications may be inferred. In all 45 subjects tested a marked decrease in
antihistaminic activity was noted in 4 hours and a complete dissipation of this
function resulted in 5 hours in 43 of them. This indicates the desirability of
administering 50 mgm. oral doses in 4 hour intervals in order to maintain an
active level of histamine-blocking activity. It is of interest that 14 subjects
demonstrated no antihistaminic action 1 hour after ingesting the same 3 com-
pounds. This group also demonstrated a sharp decline in histamine-blocking
activity in 4 hours and a disappearance of this function in 5 hours, thereby
suggesting that some individuals may require these compounds in 3 hour inter-
vals in order to maintain an active level of antihistaminic activity.
Histamine iontophoresis is also being used to study the oral and intravenous
dose response curves and the effect of pre and postprandial ingestion of anti-
histaminic drugs. The latter factor was not considered in the present or past
studies (2, 3), with the exception of those of Baer and Sulzberger (1) whose
studies were all carried out in controlled manner on an "empty stomach."
Variations in stomach and intestinal contents might account for the absence of
change in the 1 hour threshold in 14 subjects included in the present study by
slowing the absorption of antihistaminic compounds which are ingested shortly
after meals. These results will be reported in the future.
CONCLUSIONS
1. The use of histamine iontophoresis in the manner described has made it
possible to determine the duration of "histamine-blocking" activity of diphen-
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hydramine hydrochloride, tripelennamine hydrochloride and Hydryllin admin-
istered orally in single equal dosages to 45 subjects. The resulting curves of
histamine-antagonistic action of these three compounds are quite similar in all
aspects.
2. The average maximum "antihistaminic" activity was attained two hours
after the ingestion of either of these three drugs in 37 subjects. The remaining
8 reached this peak in three hours. This is later than the 50 minute interval
chosen by previous investigators for the study of the effects of ingested tripelen-
namine hydrochloride or the whealing capacity in man.
3. In five hours the histamine-blocking activity of these three compounds
completely disappeared in 43 subjects.
4. The results obtained in the present experiments indicate that diphen-
hydramine hydrochloride, tripelennamine hydrochloride and Hydryllin should
be administered orally to most individuals at four hour intervals in order to
maintain an active level of antihistaminic activity. However, a smaller number
of patients may require these compounds at three hour intervals, possibly because
of slower absorption from the gastro-intestinal tract.
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